Evaluation of the Ability of CT-based Finite Element Analysis (CTFEA) to Predict Fractures in Patients With Metastases: a Randomized Controlled Study.
- Conditions
- Bone Neoplasm of Hip (Diagnosis)Orthopedic DisorderBone MetastasesProximal Femoral Metaphyseal Abnormality
- Interventions
- Other: Conventional decision algorithmDiagnostic Test: CTFEA
- Registration Number
- NCT03453905
- Lead Sponsor
- Tel-Aviv Sourasky Medical Center
- Brief Summary
Patients with metastases to proximal femur, who are evaluated fr the risk of pathologic fracture in order to decide on preventive fixation vs follow-up constitute the study population. The patients will be randomized in two arms. First arm - the decision of treatment will rely on conventional decision algorithm including specialist judgement and Mirels' score. Second arm- the decision on treatment will be supported by CTFEA analysis of bone structure and quantitative simulation-based estimate of fracture risk, in addition to the conventional decision algorithm. Operation rates, pathologic fracture rates and additional secondary outcomes will be compared between the two study arms.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 162
- Metastatic bone disease of femur
- Patients who undergo a CT scan (soft tissue kernel/filter, 120 kVp), and have at least 2/3 of both femurs visible in the CT scan. If CT scan is performed at the Sourasky medical center it must be according to the protocol in Appendix A.
- Ipsilateral previous surgery with or without implants
- Low quality CT scan or CT does not include at least 2/3 of the femurs.
- History of fractures, radiation or surgeries in lower limbs.
- Inability to provide informed consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Mirels Conventional decision algorithm Decision on preventive surgery vs follow-up will be based on expert judgement and Mirels' score CTFEA CTFEA Decision on preventive surgery vs follow-up will be based on expert judgement, Mirels' score and CTFEA
- Primary Outcome Measures
Name Time Method Primary efficacy hypothesis four years To compare proportion of patients undergoing surgery in the treatment group vs the control group.
- Secondary Outcome Measures
Name Time Method Composite endpoint 4 months pathological fracture during 4 months of follow up OR death within 30 days after prophylactic surgery in patients who underwent surgery OR surgical complications within 4 months of follow up: infection, re-operation, mechanical failure